10-76885978-T-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001161352.2(KCNMA1):​c.*1288A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00189 in 985,414 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0084 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 13 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.169

Publications

1 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-76885978-T-A is Benign according to our data. Variant chr10-76885978-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 300934.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00837 (1274/152288) while in subpopulation AFR AF = 0.0275 (1141/41562). AF 95% confidence interval is 0.0261. There are 19 homozygotes in GnomAd4. There are 615 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*1288A>T 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*1288A>T 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.00827
AC:
1259
AN:
152170
Hom.:
16
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0272
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00694
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00574
GnomAD4 exome
AF:
0.000709
AC:
591
AN:
833126
Hom.:
13
Cov.:
32
AF XY:
0.000697
AC XY:
268
AN XY:
384726
show subpopulations
African (AFR)
AF:
0.0318
AC:
502
AN:
15786
American (AMR)
AF:
0.00102
AC:
1
AN:
984
Ashkenazi Jewish (ASJ)
AF:
0.000194
AC:
1
AN:
5152
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3632
South Asian (SAS)
AF:
0.000122
AC:
2
AN:
16460
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
276
Middle Eastern (MID)
AF:
0.00247
AC:
4
AN:
1620
European-Non Finnish (NFE)
AF:
0.0000341
AC:
26
AN:
761908
Other (OTH)
AF:
0.00201
AC:
55
AN:
27308
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
30
60
91
121
151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00837
AC:
1274
AN:
152288
Hom.:
19
Cov.:
32
AF XY:
0.00826
AC XY:
615
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0275
AC:
1141
AN:
41562
American (AMR)
AF:
0.00693
AC:
106
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000162
AC:
11
AN:
68028
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00105
Hom.:
0
Bravo
AF:
0.00945
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.9
DANN
Benign
0.64
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78082918; hg19: chr10-78645736; API